Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology News Journal.
STACK Infrastructure’s 2025 Heroes of the Sea Charitable Fundraiser Surpasses $1.3 Million Raised in a Single Year
GlobeNewswire, Inc.
·
August 12, 2025
DENVER, Aug. 12, 2025 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of data centers, today announced it raised more than...
Scientists Unveil Vaccine to Block Malaria Spread Inside Mosquitoes
MENAFN
·
August 7, 2025
(MENAFN) Australian scientists have, for the first time, visualized a crucial protein complex in malaria parasites, paving the way for a next-generation vaccine designed to disrupt the disease's transmission cycle. Led by the Melbourne-based...
Earth Science Tech, Inc. Reports 61% Asset Growth to $7.69 Million and $8.7 Million in First Quarter Revenue Following Foundational Quarter of Strategic Acquisitions
GlobeNewswire, Inc.
·
August 8, 2025
MIAMI, FL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MIAMI, FL – August 8, 2025 – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today...
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
GlobeNewswire, Inc.
·
August 8, 2025
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the...
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
GlobeNewswire, Inc.
·
August 8, 2025
TORONTO and HAIFA, Israel, Aug. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) today announced that an independent study showed that exosomes produced by NurExone...
ChatAndBuild Debuts Worldwide, Powering AI App Creation in 40+ Languages as Industry M&A Heats Up
GlobeNewswire, Inc.
·
August 8, 2025
Photo Courtesy of: ChatAndBuild LONDON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- ChatAndBuild, the AI-powered platform that turns simple ideas into real, production-ready applications - directly from your phone or laptop - is now publicly available...
Scientists develop technology that brings new precision to genome editing
Broad Institute of MIT and Harvard
·
August 6, 2025
The FDA’s recent approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome editing as a promising treatment strategy for disorders like sickle cell disease, muscular dystrophy, and certain...
Attorney General Bird Defends Iowa’s Agriculture Industry Against Radical Net Zero Standards
State of Iowa Office of the Attorney General
·
August 8, 2025
DES MOINES—Iowa Attorney General Brenna Bird today led 22 other states in a letter asking for answers regarding harmful net-zero standards. Science Based Targets (“SBTi”), which partners with both the United Nations and a group of anti-growth...
Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
GlobeNewswire, Inc.
·
August 8, 2025
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech...
Spectral Medical Announces Second Quarter and Provides Corporate Update
GlobeNewswire, Inc.
·
August 8, 2025
Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance
GlobeNewswire, Inc.
·
August 8, 2025
Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basis Total Rare Disease quarterly net revenues of $104.0 million, which includes: Purified...
CytoNiche Biotech Opens 3D FloTrix Experience Hub in Singapore to Advance Stem Cell Therapy
EIN Presswire
·
August 8, 2025
SINGAPORE, SINGAPORE, August 8, 2025 /EINPresswire.com/ -- CytoNiche Biotech, a leader in 3D cell production technology, has opened its 3D FloTrix™ Experience Hub in Singapore. This facility represents a key step in the company’s global...
Medical Device Reprocessing Market Showing Positive Growth Trends at 15.40% CAGR to 6.93 Billion USD
EIN Presswire
·
August 6, 2025
Medical Device Reprocessing Market is witnessing significant expansion, driven by the dual imperatives of sustainability and cost containment in healthcare NEW YORK , WA, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- The global Medical...
Proteomics Market Projected To Witness Substantial Growth, 2025-2032:Thermo Fisher Scientific Corporation,GE,PerkinElmer
EIN Presswire
·
August 8, 2025
BURLINGAME, CA, UNITED STATES, August 8, 2025 /EINPresswire.com/ -- The qualitative latest Research report (2025-2032) on the Proteomics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the...
Science,Technology and Innovation on launch of 2025 National Science Week
South African Government
·
August 7, 2025
Hundreds of learners and parents attended the official launch of this year's National Science Week (NSW), which took place at the Tshwane University of Technology (TUT) main campus in Pretoria West on Saturday, 4 August. The Minister of Science,...
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
GlobeNewswire, Inc.
·
August 8, 2025
Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2025. The full...
Medical Workers Face Hidden Cancer Risk from Sterilization Gas; New Test from Air by CCSquared Offers Early Detection
GlobeNewswire, Inc.
·
August 6, 2025
DEERFIELD BEACH, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sterilization gas lingers in packaging materials and outgasses during shipping, delivery, storage, and use—posing invisible risks to medical workers A growing body of government data now...
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 7, 2025
BOTHELL, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial...
Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 7, 2025
Patient Enrollment Advances in Global Phase 3 Program for Treatment of HCV Four Scientific Posters Presented at EASL, Including Final Results from Phase 2 Study of Bemnifosbuvir/Ruzasvir Regimen Confirming 98% Sustained Virologic Response at 12...
Crinetics Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire, Inc.
·
August 7, 2025
Regulatory Interactions and Commercial, Medical and Corporate Preparations On-Track for PALSONIFY™ (paltusotine) New Drug Application with September 25, 2025 PDUFA Date Continued Progress on the Global Development Program for Atumelnant Across...